大型自膨式肺动脉瓣内瓣中瓣配置的流体力学性能与移位稳定性病例及台架测试
一例Noonan综合征合并严重淋巴管疾病的年轻女性,因重度肺动脉瓣反流植入36–25 mm VenusP瓣膜,6年后行瓣中瓣植入第二枚同型号VenusP瓣膜,2年随访无收缩期压差且仅微量反流。台架测试评估多种瓣中瓣配置,显示瓣叶活动不受限、有效瓣口面积达标、反流分数为个位数。适当尺寸的内瓣在标准条件下无移位,明显过小的配置在较高压力下不稳定。
要点
- 大型自膨式VenusP瓣膜内行瓣中瓣植入在病例中2年功能良好。
- 台架测试支持适当尺寸内瓣的流体力学性能与移位稳定性。
- 明显过小的内瓣配置在较高压力下可能不稳定。
核心结论
- 在大型自膨式VenusP瓣膜内行瓣中瓣植入可行,病例2年随访功能良好。
- 台架测试显示适当尺寸的内瓣流体力学性能良好且无移位。
研究设计与样本
- 病例报告:1例Noonan综合征合并严重淋巴管疾病的年轻女性患者。
- 体外台架测试:在脉动流系统中评估多种瓣中瓣配置。
主要发现
- 病例中瓣中瓣植入后经球囊扩张改善了瓣架不完全贴壁,2年随访无收缩期压差且仅微量肺动脉瓣反流。
- 所有台架测试配置均显示内瓣瓣架完全扩张、瓣叶活动不受限,有效瓣口面积超过预设接受阈值,反流分数为个位数。
- 在标准条件下,比外瓣小1至2号的内瓣无移位,明显过小的配置在较高压力下表现出不稳定性。
关键数值与推荐
- 首次植入为36–25 mm VenusP瓣膜,6年后瓣膜出现轻度压差增加及中度反流,心脏磁共振反流分数为30%。
- 再次介入时植入第二枚36–25 mm VenusP瓣膜。
- 台架测试中所有配置的反流分数均为个位数。
临床怎么用
- 对于大型自膨式肺动脉瓣退化,可考虑植入相同型号或适当小尺寸的瓣中瓣。
- 瓣中瓣植入后瓣架不完全贴壁时,可考虑球囊扩张改善贴壁。
局限性
- 病例仅为单例报告。
- 需进一步的临床前和临床评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ABSTRACT Valve-in-valve (ViV) implantation offers a less invasive treatment for degenerated bioprostheses. However, experience with ViV implantation in large self-expanding pulmonary valves is limited, and optimal sizing and stability remain uncertain. A young woman with Noonan syndrome and severe lymphatic disorder underwent implantation of a 36–25 mm VenusP-valve (Venus Medtech) for severe pulmonary regurgitation. Six years later, the valve showed a mild gradient increase and moderate regurgitation (cardiac magnetic resonance regurgitation fraction of 30%). Given her severe lymphatic disorder, repeat percutaneous valve implantation was performed. A second 36–25 mm VenusP-valve was implanted within the existing valve. Incomplete frame apposition was improved with balloon dilation. At 2-year follow-up, there was no systolic gradient and only trace pulmonary regurgitation. Multiple ViV configurations were evaluated in a pulsatile flow system, including one-size-smaller VenusP-valves, a balloon expandable valve, and modified self-expanding valves with flares removed. Effective orifice area (EOA) and regurgitation fraction (RF), including central and paravalvular leakage, were assessed. All configurations showed complete inner-frame expansion and unrestricted leaflet motion, with EOA exceeding predefined acceptance thresholds and RF remaining in the single-digit range. No migration occurred with inner valves one to two sizes smaller than the outer valve under standard conditions, whereas substantially undersized configurations demonstrated instability at higher pressures. ViV implantation within a large self-expanding VenusP-valve was feasible, with favorable function at 2 years. Bench testing demonstrated favorable hydrodynamic performance and supported the stability of appropriately sized inner valves. Further preclinical and clinical evaluation is warranted.
引用
- Catheterization and Cardiovascular Interventions:Case Example and Bench Testing of Hydrodynamic Performance and Migration Stability of Various Valve‐in‐Valve Configurations within a Large‐Housing Self‐Expanding Pulmonary Valve
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。